Research and Markets: Global Preventive Asthma Drugs Market 2011-2015 Report: AstraZeneca, GSK, Merck and Novartis AG …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/4cb7jq/global_preventive) has announced the addition of the "Global Preventive Asthma Drugs Market 2011-2015" report to their offering.

TechNavio's analysts forecast the Global Preventive Asthma Drugs market to grow at a CAGR of 4.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing incidence of asthma. The Global Preventive Asthma Drugs market has also been witnessing the trend of an increased focus on contract manufacturing outsourcing. However, the increasing generic competition could pose a challenge to the growth of this market.

TechNavio's report, the Global Preventive Asthma Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Preventive Asthma Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are AstraZeneca plc., GlaxoSmithKline plc., Merck & Co.Inc., Novartis AG

Key questions answered in this report:

Key Topics Covered:

01. Executive Summary

02. Introduction

03. Market Coverage

Read the rest here:
Research and Markets: Global Preventive Asthma Drugs Market 2011-2015 Report: AstraZeneca, GSK, Merck and Novartis AG ...